Skip to main content
Premium Trial:

Request an Annual Quote

A Thief in the Night?


Craig Thompson, the CEO and president of the Memorial Sloan-Kettering Cancer Center, is being accused of taking research belonging to a University of Pennsylvania cancer institute and using it to start a pharmaceutical company, reports Pharmalot's Ed Silverman. The Abramson Family Cancer Research Institute at the University of Pennsylvania — where Thompson was a faculty member from 1999 until 2010 — says Thompson did not honor an agreement stating that any scientific discoveries made there belongs to the institute and thus has made $110 million so far from intellectual property that doesn't belong to him. "His work at the Institute involved developing a cancer metabolism research platform that was designed to examine the role that metabolic changes play in the origins, progression and death of cancer cells," Silverman says. "However, Thompson later co-founded Agios Pharmaceuticals, which was focused on researching cancer metabolism to develop new treatments." The institute says Thompson has caused about $1 billion in damages, and has included Agios in its lawsuit. Thompson did not comment to Silverman.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.